Article
Identifying therapeutic targets for rheumatoid arthritis by genomics-driven integrative approaches
2024-03-20
Abstract excerpt
<h4>Summary</h4> Genomics-driven drug discovery framework holds promise in developing novel therapeutic targets. Here, we leveraged large-scale genomic data including genome-wide association studies (GWAS), rare variant burden tests in exome sequencing studies (Exome), and protein quantitative trait loci (pQTL), to prioritize potential therapeutic targets and identify opportunities for drug repositioning in rheuma...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4aa10a53-f852-5a06-83a9-8aae0adad062
- DOI
- 10.1101/2024.03.19.24304536
